These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30085149)

  • 41. Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study.
    Llanos-Cuentas A; Lacerda MV; Rueangweerayut R; Krudsood S; Gupta SK; Kochar SK; Arthur P; Chuenchom N; Möhrle JJ; Duparc S; Ugwuegbulam C; Kleim JP; Carter N; Green JA; Kellam L
    Lancet; 2014 Mar; 383(9922):1049-58. PubMed ID: 24360369
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study.
    Spring MD; Lin JT; Manning JE; Vanachayangkul P; Somethy S; Bun R; Se Y; Chann S; Ittiverakul M; Sia-ngam P; Kuntawunginn W; Arsanok M; Buathong N; Chaorattanakawee S; Gosi P; Ta-aksorn W; Chanarat N; Sundrakes S; Kong N; Heng TK; Nou S; Teja-isavadharm P; Pichyangkul S; Phann ST; Balasubramanian S; Juliano JJ; Meshnick SR; Chour CM; Prom S; Lanteri CA; Lon C; Saunders DL
    Lancet Infect Dis; 2015 Jun; 15(6):683-91. PubMed ID: 25877962
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Population pharmacokinetics of artesunate and dihydroartemisinin following single- and multiple-dosing of oral artesunate in healthy subjects.
    Tan B; Naik H; Jang IJ; Yu KS; Kirsch LE; Shin CS; Craft JC; Fleckenstein L
    Malar J; 2009 Dec; 8():304. PubMed ID: 20021657
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetics of dihydroartemisinin following oral artesunate treatment of pregnant women with acute uncomplicated falciparum malaria.
    McGready R; Stepniewska K; Ward SA; Cho T; Gilveray G; Looareesuwan S; White NJ; Nosten F
    Eur J Clin Pharmacol; 2006 May; 62(5):367-71. PubMed ID: 16552504
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The pharmacokinetics of oral dihydroartemisinin and artesunate in healthy Thai volunteers.
    Na-Bangchang K; Krudsood S; Silachamroon U; Molunto P; Tasanor O; Chalermrut K; Tangpukdee N; Matangkasombut O; Kano S; Looareesuwan S
    Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):575-82. PubMed ID: 15689069
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Primaquine in Plasma and Methemoglobinemia in Patients with Malaria Due to
    Vieira JL; Ferreira MES; Ferreira MVD; Gomes MM
    Am J Trop Med Hyg; 2017 May; 96(5):1171-1175. PubMed ID: 28440745
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and safety of artemisinin-based combination therapy and chloroquine with concomitant primaquine to treat Plasmodium vivax malaria in Brazil: an open label randomized clinical trial.
    Daher A; Pereira D; Lacerda MVG; Alexandre MAA; Nascimento CT; Alves de Lima E Silva JC; Tada M; Ruffato R; Maia I; Dos Santos TC; Marchesini P; Santelli AC; Lalloo DG
    Malar J; 2018 Jan; 17(1):45. PubMed ID: 29361939
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Monitoring antimalarial drug efficacy in the Greater Mekong Subregion: an overview of in vivo results from 2008 to 2010.
    Bustos MD; Wongsrichanalai C; Delacollette C; Burkholder B
    Southeast Asian J Trop Med Public Health; 2013; 44 Suppl 1():201-30; discussion 306-7. PubMed ID: 24159833
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Design, synthesis and evaluation of antimalarial potential of polyphosphazene linked combination therapy of primaquine and dihydroartemisinin.
    Kumar S; Singh RK; Sharma R; Murthy RS; Bhardwaj TR
    Eur J Pharm Sci; 2015 Jan; 66():123-37. PubMed ID: 25312346
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Safety, efficacy and pharmacokinetic evaluations of a new coated chloroquine tablet in a single-arm open-label non-comparative trial in Brazil: a step towards a user-friendly malaria vivax treatment.
    Pereira D; Daher A; Zanini G; Maia I; Fonseca L; Pitta L; Ruffato R; Marchesini P; Fontes CJ
    Malar J; 2016 Sep; 15():477. PubMed ID: 27639847
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The influence of food on the pharmacokinetics of piperaquine in healthy Vietnamese volunteers.
    Hai TN; Hietala SF; Van Huong N; Ashton M
    Acta Trop; 2008 Aug; 107(2):145-9. PubMed ID: 18585670
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of Efficacy of Chloroquine for Plasmodium Vivax Infection Using Parasite Clearance Times: A 10-Year Study and Systematic Review.
    Subramony H; Tangpukdee N; Krudsood S; Poovorawan K; Muangnoicharoen S; Wilairatana P
    Ann Acad Med Singap; 2016 Jul; 45(7):303-14. PubMed ID: 27523511
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical efficacy of chloroquine versus artemether-lumefantrine for Plasmodium vivax treatment in Thailand.
    Krudsood S; Tangpukdee N; Muangnoicharoen S; Thanachartwet V; Luplertlop N; Srivilairit S; Wilairatana P; Kano S; Ringwald P; Looareesuwan S
    Korean J Parasitol; 2007 Jun; 45(2):111-4. PubMed ID: 17570973
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Therapeutic and Transmission-Blocking 
Efficacy of Dihydroartemisinin/Piperaquine and Chloroquine against Plasmodium vivax Malaria, Cambodia.
    Popovici J; Vantaux A; Primault L; Samreth R; Piv EP; Bin S; Kim S; Lek D; Serre D; Menard D
    Emerg Infect Dis; 2018 Aug; 24(8):1516-1519. PubMed ID: 29798745
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacokinetic properties of single-dose primaquine in Papua New Guinean children: feasibility of abbreviated high-dose regimens for radical cure of vivax malaria.
    Moore BR; Salman S; Benjamin J; Page-Sharp M; Robinson LJ; Waita E; Batty KT; Siba P; Mueller I; Davis TM; Betuela I
    Antimicrob Agents Chemother; 2014; 58(1):432-9. PubMed ID: 24189254
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metabolism of Piperaquine to Its Antiplasmodial Metabolites and Their Pharmacokinetic Profiles in Healthy Volunteers.
    Liu H; Zhou H; Cai T; Yang A; Zang M; Xing J
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29784841
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetics and ex vivo antimalarial activity of artesunate-azithromycin in healthy volunteers.
    Chinh NT; Quang NN; Anh CX; Thanh NX; Dai B; Birrell GW; Chavchich M; Edstein MD
    Antimicrob Agents Chemother; 2011 Sep; 55(9):4412-5. PubMed ID: 21730120
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison.
    Ratcliff A; Siswantoro H; Kenangalem E; Maristela R; Wuwung RM; Laihad F; Ebsworth EP; Anstey NM; Tjitra E; Price RN
    Lancet; 2007 Mar; 369(9563):757-765. PubMed ID: 17336652
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Five cases of Plasmodium vivax malaria treated with artemisinin derivatives: the advantages of a unified approach to treatment.
    Corpolongo A; Pisapia R; Oliva A; Giancola ML; Mencarini P; Bevilacqua N; Ghirga P; Mariano A; Vulcano A; Paglia MG; Nicastri E
    Infection; 2019 Aug; 47(4):655-659. PubMed ID: 30809760
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Is primaquine useful and safe as true exo-erythrocytic merontocidal, hypnozoitocidal and gametocidal antimalarial drug?
    López-Antuñano FJ
    Salud Publica Mex; 1999; 41(5):410-9. PubMed ID: 11142837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.